نتایج جستجو برای: chronic gvhd

تعداد نتایج: 500551  

2005
Rainer Storb H. Joachim Deeg Lloyd Fisher Frederick Appelbaum C. Dean Buckner William Bensinger Reginald Clift Kristine Doney Claude Irle Robert McGuffin Paul Martin Jean Sanders Gary Schoch Jack Singer Patricia Stewart Keith Sullivan Robert Witherspoon

One hundred seventy-nine patients with acute nonlymphoblastic leukemia in first remission (n = 75). chronic myelocytic leukemia in chronic or accelerated phase (n = 48) or leukemia in advanced stage (n = 56) were given HLAidentical marrow grafts and randomized to receive methotrexate or cyclosporine for prevention of graftv-host disease (GVHD). The current report updates the three prospective t...

Journal: :Medicinski arhiv 2011
Svetlana Krstevska Sonja Genadieva-Stavric Aleksandra Pivkova Zlate Stojanovski Borce Georgievski Trajan Balkanov

INTRODUCTION The transplantation of hematopoietic stem cells (HSCT) is a therapeutic intervention where the hematopoietic stem cells and the cells originating from them are being removed and replaced by the normal stem cells of donor or the patient him/her-self. HSCT today represent standardized biological manipulation for treating malignant, genetic and autoimmune diseases. The application of ...

Journal: :Blood 2013
Effie W Petersdorf

Acute graft-versus-host disease (GVHD) afflicts as much as 80% of all patients who receive an unrelated donor hematopoietic cell transplant (HCT) for the treatment of blood disorders, even with optimal donor HLA matching and use of prophylactic immunosuppressive agents. Of patients who develop acute GVHD, many are at risk for chronic GVHD and bear the burden of considerable morbidity and lowere...

Journal: :Current hematologic malignancy reports 2014
Frédéric Baron Stéphanie Humblet-Baron Grégory Ehx Sophie Servais Muriel Hannon Ludovic Belle Chantal Lechanteur Alexandra Briquet Olivier Giet Etienne Baudoux Evelyne Willems Yves Beguin

Graft-versus-host disease (GVHD) remains a major limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Despite major advances in the understanding of GVHD pathogenesis, standard GVHD prophylaxis regimens continue to be based on the combination of a calcineurin inhibitor with an antimetabolite, while first line treatments still rely on high-dose corticosteroids. Further, no sec...

2006
Howard M. Shulman David Kleiner Stephanie J. Lee Thomas Morton Steven Z. Pavletic Evan Farmer J. Margaret Moresi Joel Greenson Anne Janin Paul J. Martin George McDonald Mary E. D. Flowers Maria Turner Jane Atkinson Jay Lefkowitch M. Kay Washington Victor G. Prieto Stella K. Kim Zsolt Argenyi A. Hafeez Diwan Asif Rashid Kim Hiatt Dan Couriel Kirk Schultz Sharon Hymes Georgia B. Vogelsang

This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the management of hematopoietic cell transplantation patients. Optimal sampling and tissue preparation are discussed. Minimal criteria for the diagnosis of graft-versus-host disease (GVHD) are proposed, together with specific requirements for the d...

Journal: :Journal of immunology 1999
T Okubo E Hagiwara S Ohno T Tsuji A Ihata A Ueda A Shirai I Aoki K Okuda J Miyazaki Y Ishigatsubo

The transfer of DBA/2 spleen cells into (C57BL/10 x DBA/2)F1 mice induces chronic graft-vs-host disease (GVHD), which is characterized by the production of Th2 cytokines, hypergammaglobulinemia, and immune complex-mediated glomerulonephritis like systemic lupus erythematosus. IL-12 strongly induces the production of Th1 cytokines and reduces Th2 activity in vivo. In this study, the effect of ge...

Journal: :Bone Marrow Transplantation 2014

Journal: :Biology of Blood and Marrow Transplantation 2008

Journal: :Haematologica 2006
Joaquín Sánchez-García Josefina Serrano Pedro Gómez Francisco Martínez Carmen Martín José Román-Gómez Antonia Rodríguez Concepción Herrera José M García Miguel A Alvarez Antonio Torres

BACKGROUND AND OBJECTIVES The development of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (SCT) for B-lineage acute lymphoblastic leukemia (B-ALL) is associated with a lower probability of leukemia relapse. However, mechanisms by which this GVHD-associated graft-versus-leukemia effect is exerted are poorly understood. In this study, we simultaneously traced the ki...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید